Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Status: Recruiting
Location: See all (40) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this study is to identify and characterize patients with known Type 2 Diabetes Mellitus (T2DM) for possible participation in ongoing or future T2DM clinical studies, and to characterize trends in key concomitant medication use in this patient population across different geographical regions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Participants must be ≥ 18 years of age at the time of signing the ICF.

• Patients with a diagnosis of T2DM, test- or documentation-confirmed as per World

• Health Organization or local diagnostic standards, inadequately managed with:

⁃ Lifestyle management alone, AND/OR

⁃ A stable dose of background glucose-lowering medication(s) for T2DM (As specified in the Protocol) for at least 45 days prior to signing the ICF.

∙ Expresses interest in participating in an ongoing or future T2DM clinical study, is motivated and willing to make themselves available for the duration of the study, and is able to follow study procedures as required.

‣ Provision of signed and dated written informed consent (As specified in the Protocol) before any study-specific procedures, sampling, or analysis.

Locations
United States
California
Research Site
RECRUITING
Lincoln
Florida
Research Site
NOT_YET_RECRUITING
Ocoee
Georgia
Research Site
NOT_YET_RECRUITING
Decatur
Maryland
Research Site
NOT_YET_RECRUITING
Potomac
South Carolina
Research Site
NOT_YET_RECRUITING
Gaffney
Washington
Research Site
NOT_YET_RECRUITING
Renton
Other Locations
Brazil
Research Site
NOT_YET_RECRUITING
Barretos
Research Site
NOT_YET_RECRUITING
Brasília
Research Site
NOT_YET_RECRUITING
Campinas
Research Site
NOT_YET_RECRUITING
Curitiba
Research Site
NOT_YET_RECRUITING
Fortaleza
Research Site
NOT_YET_RECRUITING
Natal
Research Site
NOT_YET_RECRUITING
Porto Alegre
Research Site
NOT_YET_RECRUITING
Rio De Janeiro
Research Site
NOT_YET_RECRUITING
São José Dos Campos
Research Site
NOT_YET_RECRUITING
São Paulo
Research Site
NOT_YET_RECRUITING
São Paulo
China
Research Site
NOT_YET_RECRUITING
Tianjin
Malaysia
Research Site
NOT_YET_RECRUITING
Batu Caves
Research Site
NOT_YET_RECRUITING
Kuala Lumpur
Research Site
NOT_YET_RECRUITING
Putrajaya
Research Site
NOT_YET_RECRUITING
Seremban
Research Site
NOT_YET_RECRUITING
Seri Manjung
Poland
Research Site
NOT_YET_RECRUITING
Bialystok
Research Site
NOT_YET_RECRUITING
Częstochowa
Research Site
NOT_YET_RECRUITING
Kielce
Research Site
NOT_YET_RECRUITING
Krakow
Research Site
NOT_YET_RECRUITING
Lodz
Research Site
NOT_YET_RECRUITING
Lublin
Research Site
NOT_YET_RECRUITING
Poznan
Research Site
NOT_YET_RECRUITING
Radom
Research Site
NOT_YET_RECRUITING
Warsaw
Turkey
Research Site
NOT_YET_RECRUITING
Adana
Research Site
NOT_YET_RECRUITING
Ankara
Research Site
NOT_YET_RECRUITING
Ankara
Research Site
NOT_YET_RECRUITING
Gaziantep
Research Site
NOT_YET_RECRUITING
Istanbul
Research Site
NOT_YET_RECRUITING
Istanbul
Research Site
NOT_YET_RECRUITING
Kayseri
Research Site
NOT_YET_RECRUITING
Yüreğir
Contact Information
Primary
AstraZeneca Clinical Study Information Center
information.center@astrazeneca.com
1-877-240-9479
Time Frame
Start Date: 2026-05-06
Estimated Completion Date: 2027-03-31
Participants
Target number of participants: 3000
Treatments
Participants with Type 2 Diabetes
Participants with Type 2 Diabetes
Related Therapeutic Areas
Sponsors
Leads: AstraZeneca

This content was sourced from clinicaltrials.gov